Makhtar Camara

Safety, immunogenicity, and efficacy of the candidate tuberculosis vaccine MVA85A in healthy adults infected with HIV-1: a randomised, placebo-controlled, phase 2 trial

B Ndiaye, Friedrich Thienemann, Martin O. C. Ota et al. · The Lancet Respiratory Medicine · 2015 · 160 citations · Full text

T-Helper 17 Cells Are Associated With Pathology in Human Schistosomiasis

Moustapha Mbow, Bridget Larkin, Lynn Meurs et al. · The Journal of Infectious Diseases · 2012 · 94 citations · Full text

Safety, reactogenicity, and immunogenicity of a chimpanzee adenovirus vectored Ebola vaccine in adults in Africa: a randomised, observer-blind, placebo-controlled, phase 2 trial

Milagritos D. Tapia, Samba O. Sow, B Ndiaye et al. · The Lancet Infectious Diseases · 2020 · 75 citations · Full text

Vaccination, Vaccine Safety, Vaccine Development +8

Multisite Evaluation of a Point-of-Care Instrument for CD4+ T-Cell Enumeration Using Venous and Finger-Prick Blood

Papa Alassane Diaw, Géraldine Daneau, Abdoul Aziz Coly et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 2011 · 72 citations

Absolute CD4 T-Cell Counting in Resource-Poor Settings

Tandakha Ndiaye Dièye, Chris Vereecken, Abdoul Aziz Diallo et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 2005 · 66 citations

Resource-poor Settings, Measurement, Blood Cell +17